| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lyme Disease | 44 | 2023 | 621 | 12.190 |
Why?
|
| Meningitis, Bacterial | 34 | 2022 | 218 | 6.840 |
Why?
|
| Head Injuries, Closed | 7 | 2019 | 136 | 3.190 |
Why?
|
| Spinal Puncture | 15 | 2020 | 281 | 2.800 |
Why?
|
| Diabetic Ketoacidosis | 13 | 2023 | 247 | 2.540 |
Why?
|
| Serologic Tests | 8 | 2021 | 374 | 2.490 |
Why?
|
| Emergency Service, Hospital | 57 | 2023 | 7659 | 2.330 |
Why?
|
| Immunoenzyme Techniques | 7 | 2021 | 1799 | 2.280 |
Why?
|
| Meningitis, Aseptic | 9 | 2013 | 59 | 2.170 |
Why?
|
| Bacterial Infections | 10 | 2022 | 1401 | 2.020 |
Why?
|
| Cerebrospinal Fluid Shunts | 5 | 2018 | 189 | 2.000 |
Why?
|
| Fever | 21 | 2023 | 1614 | 1.930 |
Why?
|
| Meningitis | 7 | 2023 | 216 | 1.700 |
Why?
|
| Meningitis, Viral | 6 | 2017 | 50 | 1.610 |
Why?
|
| Decision Support Techniques | 13 | 2019 | 1955 | 1.600 |
Why?
|
| Cerebrospinal Fluid | 14 | 2021 | 534 | 1.500 |
Why?
|
| Lyme Neuroborreliosis | 5 | 2020 | 51 | 1.450 |
Why?
|
| Borrelia burgdorferi | 7 | 2021 | 180 | 1.400 |
Why?
|
| Child | 116 | 2023 | 77679 | 1.390 |
Why?
|
| Wounds, Nonpenetrating | 7 | 2015 | 794 | 1.350 |
Why?
|
| Infant | 91 | 2023 | 35129 | 1.280 |
Why?
|
| Endemic Diseases | 5 | 2020 | 182 | 1.280 |
Why?
|
| Leukocyte Count | 13 | 2022 | 1584 | 1.260 |
Why?
|
| Arthritis, Infectious | 6 | 2022 | 367 | 1.250 |
Why?
|
| Polymerase Chain Reaction | 11 | 2019 | 6172 | 1.240 |
Why?
|
| Bacteremia | 13 | 2022 | 962 | 1.240 |
Why?
|
| Facial Paralysis | 4 | 2017 | 338 | 1.210 |
Why?
|
| Skull Fractures | 4 | 2020 | 195 | 1.200 |
Why?
|
| Leukocytosis | 10 | 2021 | 247 | 1.190 |
Why?
|
| Fluid Therapy | 9 | 2023 | 593 | 1.150 |
Why?
|
| Immunoblotting | 3 | 2019 | 1682 | 1.120 |
Why?
|
| Erythema Chronicum Migrans | 2 | 2023 | 47 | 1.110 |
Why?
|
| Enterovirus | 4 | 2017 | 64 | 1.040 |
Why?
|
| Child, Preschool | 62 | 2023 | 40992 | 1.030 |
Why?
|
| Enterovirus Infections | 5 | 2017 | 72 | 1.020 |
Why?
|
| Sensitivity and Specificity | 31 | 2021 | 14726 | 1.010 |
Why?
|
| Synovial Fluid | 3 | 2022 | 394 | 0.990 |
Why?
|
| Brain Injuries | 7 | 2022 | 2025 | 0.980 |
Why?
|
| Ceftriaxone | 4 | 2023 | 168 | 0.970 |
Why?
|
| Anti-Bacterial Agents | 18 | 2022 | 7179 | 0.940 |
Why?
|
| Craniocerebral Trauma | 6 | 2020 | 482 | 0.900 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2020 | 20123 | 0.880 |
Why?
|
| Cerebrospinal Fluid Proteins | 5 | 2018 | 69 | 0.850 |
Why?
|
| Adolescent | 70 | 2023 | 85759 | 0.810 |
Why?
|
| Ondansetron | 2 | 2020 | 89 | 0.810 |
Why?
|
| Bicycling | 2 | 2014 | 176 | 0.800 |
Why?
|
| Antibodies, Bacterial | 7 | 2021 | 1470 | 0.790 |
Why?
|
| Doxycycline | 2 | 2023 | 326 | 0.760 |
Why?
|
| Ixodes | 1 | 2020 | 39 | 0.760 |
Why?
|
| Accidents, Traffic | 4 | 2015 | 819 | 0.760 |
Why?
|
| Antiemetics | 2 | 2020 | 176 | 0.750 |
Why?
|
| Herpes Simplex | 6 | 2022 | 470 | 0.730 |
Why?
|
| Clinical Enzyme Tests | 1 | 2019 | 115 | 0.710 |
Why?
|
| Immunoglobulin M | 5 | 2021 | 1538 | 0.700 |
Why?
|
| Complement C6 | 1 | 2018 | 21 | 0.680 |
Why?
|
| Infant, Newborn | 47 | 2022 | 25618 | 0.680 |
Why?
|
| Otitis Media | 2 | 2020 | 277 | 0.680 |
Why?
|
| Retrospective Studies | 76 | 2023 | 77426 | 0.670 |
Why?
|
| Skull | 2 | 2015 | 813 | 0.660 |
Why?
|
| Pediatrics | 9 | 2021 | 3469 | 0.660 |
Why?
|
| Diagnosis, Differential | 19 | 2022 | 12961 | 0.630 |
Why?
|
| Herpes Zoster Oticus | 1 | 2017 | 8 | 0.630 |
Why?
|
| Hospitals, Pediatric | 11 | 2019 | 1766 | 0.630 |
Why?
|
| Humans | 186 | 2023 | 744220 | 0.630 |
Why?
|
| Hospitalization | 14 | 2021 | 10262 | 0.630 |
Why?
|
| Glasgow Coma Scale | 7 | 2021 | 570 | 0.620 |
Why?
|
| Urinary Tract Infections | 7 | 2022 | 788 | 0.620 |
Why?
|
| Multi-Institutional Systems | 1 | 2017 | 43 | 0.600 |
Why?
|
| Cross-Sectional Studies | 37 | 2023 | 25043 | 0.590 |
Why?
|
| Emergency Medicine | 4 | 2021 | 1207 | 0.590 |
Why?
|
| Facial Nerve Injuries | 1 | 2017 | 63 | 0.590 |
Why?
|
| C-Reactive Protein | 3 | 2019 | 3778 | 0.570 |
Why?
|
| Bibliometrics | 1 | 2020 | 339 | 0.560 |
Why?
|
| Male | 109 | 2023 | 350027 | 0.560 |
Why?
|
| Publishing | 2 | 2020 | 833 | 0.550 |
Why?
|
| Female | 110 | 2023 | 380197 | 0.540 |
Why?
|
| Simplexvirus | 4 | 2022 | 802 | 0.530 |
Why?
|
| Knee Joint | 3 | 2022 | 1680 | 0.520 |
Why?
|
| Bacteria | 6 | 2022 | 2114 | 0.520 |
Why?
|
| Accidental Falls | 2 | 2014 | 1062 | 0.510 |
Why?
|
| Prospective Studies | 27 | 2023 | 53280 | 0.500 |
Why?
|
| Hydrocephalus | 3 | 2018 | 748 | 0.500 |
Why?
|
| Rheumatology | 5 | 2021 | 576 | 0.500 |
Why?
|
| Emergency Treatment | 4 | 2021 | 517 | 0.490 |
Why?
|
| Nursing Diagnosis | 1 | 2013 | 18 | 0.470 |
Why?
|
| Physician-Nurse Relations | 1 | 2013 | 20 | 0.470 |
Why?
|
| Advisory Committees | 1 | 2017 | 774 | 0.430 |
Why?
|
| Mental Recall | 1 | 2019 | 1205 | 0.430 |
Why?
|
| Quality Improvement | 3 | 2017 | 3746 | 0.420 |
Why?
|
| Periodicals as Topic | 2 | 2020 | 1432 | 0.420 |
Why?
|
| Clinical Medicine | 1 | 2013 | 147 | 0.410 |
Why?
|
| Cervical Vertebrae | 4 | 2013 | 975 | 0.410 |
Why?
|
| Spinal Injuries | 2 | 2012 | 301 | 0.400 |
Why?
|
| Trauma Severity Indices | 5 | 2015 | 481 | 0.400 |
Why?
|
| Informed Consent | 1 | 2018 | 995 | 0.400 |
Why?
|
| Hip Joint | 1 | 2018 | 1002 | 0.390 |
Why?
|
| Neutrophils | 4 | 2018 | 3717 | 0.370 |
Why?
|
| Cohort Studies | 25 | 2023 | 40559 | 0.360 |
Why?
|
| Arthropod Vectors | 1 | 2008 | 6 | 0.340 |
Why?
|
| Tularemia | 1 | 2008 | 36 | 0.330 |
Why?
|
| Blood Sedimentation | 2 | 2019 | 231 | 0.320 |
Why?
|
| Parents | 3 | 2019 | 3407 | 0.320 |
Why?
|
| Tick-Borne Diseases | 1 | 2008 | 34 | 0.320 |
Why?
|
| Emergencies | 3 | 2021 | 1170 | 0.320 |
Why?
|
| Blood Cell Count | 4 | 2019 | 402 | 0.320 |
Why?
|
| Research | 1 | 2017 | 1999 | 0.320 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3871 | 0.320 |
Why?
|
| Child Abuse | 1 | 2017 | 1030 | 0.320 |
Why?
|
| Glucose | 5 | 2023 | 4396 | 0.320 |
Why?
|
| Francisella tularensis | 1 | 2008 | 56 | 0.320 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 738 | 0.310 |
Why?
|
| Predictive Value of Tests | 14 | 2021 | 15070 | 0.300 |
Why?
|
| Emergency Medical Services | 4 | 2021 | 1916 | 0.300 |
Why?
|
| Pneumococcal Vaccines | 2 | 2008 | 391 | 0.300 |
Why?
|
| False Negative Reactions | 2 | 2020 | 587 | 0.300 |
Why?
|
| Lyme Disease Vaccines | 1 | 2006 | 18 | 0.290 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 403 | 0.280 |
Why?
|
| Insulin | 1 | 2021 | 6583 | 0.280 |
Why?
|
| Vomiting | 2 | 2020 | 635 | 0.280 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3820 | 0.280 |
Why?
|
| Status Epilepticus | 3 | 2017 | 444 | 0.280 |
Why?
|
| Central Nervous System Viral Diseases | 2 | 2018 | 39 | 0.270 |
Why?
|
| Thrombocytosis | 1 | 2006 | 81 | 0.270 |
Why?
|
| Boston | 8 | 2019 | 9311 | 0.270 |
Why?
|
| Erythrocytes | 3 | 2017 | 2454 | 0.270 |
Why?
|
| Guideline Adherence | 2 | 2015 | 2266 | 0.260 |
Why?
|
| Skin Pigmentation | 1 | 2007 | 282 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2018 | 4687 | 0.260 |
Why?
|
| United States | 29 | 2021 | 69867 | 0.250 |
Why?
|
| Young Adult | 20 | 2021 | 56436 | 0.250 |
Why?
|
| Equipment Failure | 2 | 2018 | 579 | 0.240 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 5755 | 0.240 |
Why?
|
| Neurology | 3 | 2021 | 764 | 0.240 |
Why?
|
| Labor, Obstetric | 1 | 2007 | 333 | 0.240 |
Why?
|
| Length of Stay | 6 | 2019 | 6308 | 0.240 |
Why?
|
| Health Services Research | 3 | 2021 | 1836 | 0.240 |
Why?
|
| False Positive Reactions | 2 | 2016 | 981 | 0.230 |
Why?
|
| Severity of Illness Index | 7 | 2020 | 15538 | 0.230 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 497 | 0.230 |
Why?
|
| Myocarditis | 2 | 2021 | 771 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2023 | 3336 | 0.220 |
Why?
|
| Urinalysis | 6 | 2022 | 369 | 0.220 |
Why?
|
| Family | 2 | 2019 | 3148 | 0.220 |
Why?
|
| Pyuria | 1 | 2022 | 30 | 0.220 |
Why?
|
| Pyomyositis | 1 | 2022 | 10 | 0.220 |
Why?
|
| Communicable Diseases | 2 | 2021 | 880 | 0.210 |
Why?
|
| Risk Factors | 22 | 2022 | 72280 | 0.210 |
Why?
|
| Infusions, Intravenous | 3 | 2023 | 2272 | 0.210 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2006 | 365 | 0.210 |
Why?
|
| Reproducibility of Results | 12 | 2020 | 19907 | 0.200 |
Why?
|
| Erythrocyte Count | 2 | 2020 | 163 | 0.200 |
Why?
|
| Pneumonia | 2 | 2023 | 2134 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 7281 | 0.190 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2006 | 546 | 0.190 |
Why?
|
| Oxadiazoles | 1 | 2001 | 93 | 0.190 |
Why?
|
| Rotavirus Infections | 1 | 2002 | 86 | 0.190 |
Why?
|
| Rotavirus | 1 | 2002 | 109 | 0.190 |
Why?
|
| Radiography | 1 | 2012 | 7022 | 0.190 |
Why?
|
| Delivery, Obstetric | 1 | 2007 | 906 | 0.180 |
Why?
|
| Societies, Medical | 3 | 2020 | 3741 | 0.180 |
Why?
|
| Brain Concussion | 3 | 2017 | 1320 | 0.180 |
Why?
|
| Delphi Technique | 2 | 2020 | 778 | 0.180 |
Why?
|
| Lymphadenitis | 1 | 2020 | 98 | 0.180 |
Why?
|
| Risk Assessment | 9 | 2021 | 23337 | 0.180 |
Why?
|
| Cerebellar Diseases | 1 | 2002 | 222 | 0.180 |
Why?
|
| Biomedical Research | 3 | 2020 | 3311 | 0.170 |
Why?
|
| Acidosis | 1 | 2021 | 272 | 0.170 |
Why?
|
| Brain Edema | 2 | 2021 | 617 | 0.170 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2007 | 1018 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2023 | 6259 | 0.170 |
Why?
|
| Immunoglobulin G | 3 | 2019 | 4559 | 0.170 |
Why?
|
| Borrelia | 1 | 2019 | 67 | 0.170 |
Why?
|
| Sodium | 2 | 2021 | 1623 | 0.170 |
Why?
|
| Bacteriuria | 1 | 2019 | 102 | 0.170 |
Why?
|
| Acute Kidney Injury | 2 | 2022 | 1971 | 0.170 |
Why?
|
| ROC Curve | 5 | 2018 | 3527 | 0.170 |
Why?
|
| Medical Errors | 1 | 2007 | 1297 | 0.160 |
Why?
|
| Rehydration Solutions | 1 | 2018 | 47 | 0.160 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2019 | 102 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2022 | 402 | 0.160 |
Why?
|
| Algorithms | 5 | 2019 | 13885 | 0.160 |
Why?
|
| Pakistan | 1 | 2018 | 296 | 0.160 |
Why?
|
| Follow-Up Studies | 11 | 2018 | 39045 | 0.150 |
Why?
|
| Ticks | 2 | 2008 | 70 | 0.150 |
Why?
|
| Scalp | 1 | 2020 | 380 | 0.150 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2019 | 1162 | 0.150 |
Why?
|
| Judgment | 1 | 2019 | 281 | 0.150 |
Why?
|
| Incidence | 9 | 2018 | 20945 | 0.150 |
Why?
|
| Encephalitis, Viral | 1 | 2017 | 55 | 0.150 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2374 | 0.150 |
Why?
|
| Financing, Organized | 1 | 2019 | 202 | 0.150 |
Why?
|
| Peer Review | 1 | 2019 | 209 | 0.150 |
Why?
|
| Multivariate Analysis | 8 | 2012 | 12244 | 0.150 |
Why?
|
| Seizures | 3 | 2021 | 2859 | 0.150 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 2291 | 0.150 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2016 | 783 | 0.150 |
Why?
|
| Hypoglycemia | 2 | 2021 | 861 | 0.140 |
Why?
|
| Antiviral Agents | 2 | 2017 | 2987 | 0.140 |
Why?
|
| Age Factors | 9 | 2021 | 18367 | 0.140 |
Why?
|
| Prevalence | 4 | 2022 | 15226 | 0.140 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 3611 | 0.140 |
Why?
|
| Authorship | 1 | 2019 | 271 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2019 | 552 | 0.140 |
Why?
|
| Musculoskeletal Diseases | 1 | 2022 | 581 | 0.140 |
Why?
|
| Trauma Centers | 2 | 2011 | 889 | 0.140 |
Why?
|
| International Cooperation | 2 | 2021 | 1421 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2020 | 764 | 0.130 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2017 | 232 | 0.130 |
Why?
|
| Seat Belts | 1 | 2015 | 57 | 0.130 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2015 | 68 | 0.130 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 712 | 0.130 |
Why?
|
| Hematoma | 1 | 2020 | 758 | 0.130 |
Why?
|
| International Classification of Diseases | 3 | 2015 | 867 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 35423 | 0.130 |
Why?
|
| Environment | 1 | 2021 | 1124 | 0.130 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2017 | 341 | 0.130 |
Why?
|
| Interinstitutional Relations | 1 | 2016 | 240 | 0.130 |
Why?
|
| Editorial Policies | 1 | 2019 | 451 | 0.120 |
Why?
|
| Nurse Practitioners | 2 | 2018 | 270 | 0.120 |
Why?
|
| Time Factors | 9 | 2020 | 40063 | 0.120 |
Why?
|
| Abscess | 1 | 2018 | 607 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 686 | 0.120 |
Why?
|
| Education, Nursing, Diploma Programs | 1 | 2013 | 11 | 0.120 |
Why?
|
| Head | 1 | 2019 | 880 | 0.120 |
Why?
|
| Ambulatory Care | 2 | 2015 | 2708 | 0.120 |
Why?
|
| Cell Count | 1 | 2018 | 1854 | 0.120 |
Why?
|
| Physical Examination | 1 | 2020 | 1238 | 0.120 |
Why?
|
| Acute Disease | 3 | 2019 | 7148 | 0.120 |
Why?
|
| Confidence Intervals | 4 | 2012 | 2970 | 0.120 |
Why?
|
| Databases, Factual | 5 | 2019 | 7730 | 0.120 |
Why?
|
| Comparative Effectiveness Research | 1 | 2018 | 681 | 0.110 |
Why?
|
| Child Restraint Systems | 1 | 2012 | 20 | 0.110 |
Why?
|
| Ataxia | 1 | 2014 | 304 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2017 | 1123 | 0.110 |
Why?
|
| Parenting | 1 | 2018 | 679 | 0.110 |
Why?
|
| Drainage | 1 | 2018 | 1141 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2022 | 21752 | 0.100 |
Why?
|
| Cognition | 3 | 2023 | 6765 | 0.100 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 159 | 0.100 |
Why?
|
| Italy | 1 | 2014 | 832 | 0.100 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 855 | 0.100 |
Why?
|
| Poisson Distribution | 1 | 2013 | 513 | 0.100 |
Why?
|
| Absenteeism | 1 | 2013 | 250 | 0.100 |
Why?
|
| Pandemics | 2 | 2023 | 8387 | 0.100 |
Why?
|
| Diarrhea | 1 | 2018 | 1347 | 0.100 |
Why?
|
| Hospital Costs | 2 | 2013 | 984 | 0.100 |
Why?
|
| Hypertension | 2 | 2023 | 8480 | 0.100 |
Why?
|
| Phenazines | 2 | 2019 | 58 | 0.100 |
Why?
|
| Gentian Violet | 2 | 2019 | 31 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2018 | 2226 | 0.100 |
Why?
|
| Caustics | 1 | 2001 | 30 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2001 | 1772 | 0.100 |
Why?
|
| Cranial Nerve Diseases | 1 | 2011 | 112 | 0.100 |
Why?
|
| Statistics, Nonparametric | 3 | 2016 | 2886 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2018 | 1255 | 0.100 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 2030 | 0.100 |
Why?
|
| Program Evaluation | 2 | 2017 | 2486 | 0.100 |
Why?
|
| Hair Preparations | 1 | 2001 | 32 | 0.100 |
Why?
|
| Health Education | 1 | 2017 | 1055 | 0.090 |
Why?
|
| Brain | 2 | 2014 | 26413 | 0.090 |
Why?
|
| Schools | 2 | 2023 | 1433 | 0.090 |
Why?
|
| Post-Concussion Syndrome | 1 | 2013 | 219 | 0.090 |
Why?
|
| Time | 1 | 2012 | 541 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 5396 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1457 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2018 | 3913 | 0.090 |
Why?
|
| Patient Discharge | 3 | 2021 | 3313 | 0.090 |
Why?
|
| Esophageal Diseases | 1 | 2001 | 166 | 0.090 |
Why?
|
| Neurosurgical Procedures | 2 | 2019 | 2003 | 0.090 |
Why?
|
| Pharyngeal Diseases | 1 | 2001 | 133 | 0.090 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 252 | 0.090 |
Why?
|
| Erythema | 1 | 2001 | 257 | 0.090 |
Why?
|
| Whooping Cough | 1 | 2010 | 82 | 0.090 |
Why?
|
| Brazil | 1 | 2013 | 1270 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2013 | 491 | 0.080 |
Why?
|
| Logistic Models | 6 | 2019 | 13409 | 0.080 |
Why?
|
| Haemophilus influenzae type b | 1 | 2008 | 16 | 0.080 |
Why?
|
| Patient Care | 1 | 2014 | 640 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1854 | 0.080 |
Why?
|
| Diptera | 1 | 2008 | 53 | 0.080 |
Why?
|
| Quality of Health Care | 3 | 2019 | 4371 | 0.080 |
Why?
|
| Meningitis, Meningococcal | 1 | 2008 | 43 | 0.080 |
Why?
|
| Linear Models | 3 | 2017 | 5953 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 546 | 0.080 |
Why?
|
| Rest | 1 | 2013 | 901 | 0.080 |
Why?
|
| Haemophilus Infections | 1 | 2008 | 95 | 0.080 |
Why?
|
| Disease Reservoirs | 1 | 2008 | 131 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2014 | 2619 | 0.080 |
Why?
|
| Neisseria meningitidis | 1 | 2008 | 109 | 0.080 |
Why?
|
| Bioterrorism | 1 | 2008 | 143 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2017 | 2400 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2001 | 241 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2015 | 1178 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2211 | 0.080 |
Why?
|
| Hyperbilirubinemia | 1 | 2007 | 77 | 0.080 |
Why?
|
| Sodium Chloride | 2 | 2021 | 625 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 2026 | 0.070 |
Why?
|
| Massachusetts | 5 | 2015 | 8663 | 0.070 |
Why?
|
| Zoonoses | 1 | 2008 | 185 | 0.070 |
Why?
|
| Cough | 1 | 2001 | 555 | 0.070 |
Why?
|
| North America | 2 | 2021 | 1250 | 0.070 |
Why?
|
| Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
| Decision Making | 3 | 2014 | 3888 | 0.070 |
Why?
|
| Rodentia | 1 | 2008 | 262 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2023 | 7908 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2458 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2001 | 696 | 0.070 |
Why?
|
| Injury Severity Score | 3 | 2017 | 1013 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1928 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 911 | 0.070 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2006 | 97 | 0.070 |
Why?
|
| Electronic Health Records | 3 | 2018 | 4463 | 0.070 |
Why?
|
| Consensus | 3 | 2020 | 2958 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6489 | 0.070 |
Why?
|
| Odds Ratio | 5 | 2021 | 9849 | 0.070 |
Why?
|
| Anaphylaxis | 1 | 2013 | 746 | 0.070 |
Why?
|
| RNA | 1 | 2016 | 2749 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2021 | 63119 | 0.070 |
Why?
|
| Education, Medical | 1 | 2018 | 1721 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2013 | 931 | 0.070 |
Why?
|
| Leukocytes | 1 | 2014 | 2040 | 0.070 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2662 | 0.060 |
Why?
|
| Latex Fixation Tests | 1 | 2004 | 32 | 0.060 |
Why?
|
| Adult | 10 | 2023 | 214035 | 0.060 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2011 | 979 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2020 | 8551 | 0.060 |
Why?
|
| Prognosis | 6 | 2020 | 29050 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2017 | 4556 | 0.060 |
Why?
|
| Headache | 1 | 2011 | 1226 | 0.060 |
Why?
|
| Arthritis, Psoriatic | 1 | 2006 | 215 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 1357 | 0.060 |
Why?
|
| Platelet Count | 1 | 2006 | 781 | 0.060 |
Why?
|
| Mass Media | 1 | 2006 | 305 | 0.060 |
Why?
|
| Medical Records | 2 | 2019 | 1413 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.060 |
Why?
|
| Canada | 2 | 2020 | 2065 | 0.060 |
Why?
|
| Athletic Injuries | 1 | 2013 | 1154 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2006 | 1005 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2012 | 10250 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 714 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2012 | 1540 | 0.050 |
Why?
|
| Blood Urea Nitrogen | 1 | 2022 | 191 | 0.050 |
Why?
|
| Seasons | 1 | 2008 | 1494 | 0.050 |
Why?
|
| Public Opinion | 1 | 2006 | 477 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2017 | 9147 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2020 | 5787 | 0.050 |
Why?
|
| Virginia | 1 | 2021 | 121 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 12805 | 0.050 |
Why?
|
| Dehydration | 1 | 2023 | 234 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1623 | 0.050 |
Why?
|
| Insect Repellents | 1 | 2020 | 17 | 0.050 |
Why?
|
| Romania | 1 | 2001 | 96 | 0.050 |
Why?
|
| Scotland | 1 | 2001 | 155 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4929 | 0.050 |
Why?
|
| Infectious Disease Medicine | 1 | 2020 | 46 | 0.050 |
Why?
|
| Sepsis | 1 | 2014 | 2593 | 0.050 |
Why?
|
| Animals | 5 | 2021 | 168788 | 0.050 |
Why?
|
| Electrolytes | 1 | 2021 | 282 | 0.050 |
Why?
|
| Drug Industry | 1 | 2006 | 745 | 0.050 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 120 | 0.040 |
Why?
|
| Oxazoles | 1 | 2001 | 189 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2017 | 1655 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2020 | 505 | 0.040 |
Why?
|
| Fellowships and Scholarships | 2 | 2020 | 1076 | 0.040 |
Why?
|
| Spain | 1 | 2020 | 465 | 0.040 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2021 | 157 | 0.040 |
Why?
|
| Chlorides | 1 | 2021 | 667 | 0.040 |
Why?
|
| Body Temperature | 1 | 2021 | 777 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 548 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2019 | 402 | 0.040 |
Why?
|
| Registries | 2 | 2011 | 8090 | 0.040 |
Why?
|
| Hospitals | 2 | 2023 | 3952 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 1420 | 0.040 |
Why?
|
| Age Distribution | 2 | 2013 | 2903 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2020 | 846 | 0.040 |
Why?
|
| Exanthema | 1 | 2021 | 501 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2007 | 2616 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2008 | 4220 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 571 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 1171 | 0.030 |
Why?
|
| Trust | 1 | 2019 | 505 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2023 | 2170 | 0.030 |
Why?
|
| Cost Savings | 1 | 2000 | 926 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2023 | 1181 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2020 | 1183 | 0.030 |
Why?
|
| Health Literacy | 1 | 2019 | 414 | 0.030 |
Why?
|
| Vaccination | 1 | 2006 | 3278 | 0.030 |
Why?
|
| Law Enforcement | 1 | 2015 | 109 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3340 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 1175 | 0.030 |
Why?
|
| Immunoassay | 1 | 2017 | 752 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 766 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6101 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2013 | 2715 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2002 | 2902 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 213367 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2006 | 5982 | 0.030 |
Why?
|
| Anxiety | 1 | 2007 | 4297 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 440 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 3023 | 0.030 |
Why?
|
| Propensity Score | 1 | 2019 | 1781 | 0.030 |
Why?
|
| Cost Control | 1 | 2015 | 624 | 0.030 |
Why?
|
| Overweight | 1 | 2023 | 2370 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6601 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1184 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2021 | 2044 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2020 | 1372 | 0.030 |
Why?
|
| Program Development | 1 | 2017 | 1315 | 0.020 |
Why?
|
| Mentors | 1 | 2016 | 630 | 0.020 |
Why?
|
| Accidents, Home | 1 | 2001 | 75 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2018 | 1209 | 0.020 |
Why?
|
| Health Care Costs | 2 | 2015 | 3209 | 0.020 |
Why?
|
| Memory | 1 | 2020 | 2174 | 0.020 |
Why?
|
| Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
| Product Labeling | 1 | 2001 | 79 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57768 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2634 | 0.020 |
Why?
|
| Accidents | 1 | 2010 | 164 | 0.020 |
Why?
|
| Health Promotion | 1 | 2021 | 2205 | 0.020 |
Why?
|
| Physicians | 2 | 2018 | 4564 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2012 | 445 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 2297 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2001 | 345 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16365 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2001 | 367 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 8343 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2021 | 3114 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2015 | 2453 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.020 |
Why?
|
| Video Recording | 1 | 2012 | 947 | 0.020 |
Why?
|
| Device Removal | 1 | 2012 | 656 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2017 | 1901 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5076 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2012 | 770 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 163253 | 0.020 |
Why?
|
| Pregnancy | 1 | 2007 | 29142 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1583 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 326 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2001 | 706 | 0.020 |
Why?
|
| Computer Systems | 1 | 2007 | 483 | 0.020 |
Why?
|
| Curriculum | 1 | 2018 | 3604 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2012 | 978 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7784 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 1948 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8321 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2013 | 2925 | 0.010 |
Why?
|
| Mass Screening | 1 | 2018 | 5252 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9685 | 0.010 |
Why?
|
| Reoperation | 1 | 2012 | 4203 | 0.010 |
Why?
|
| Cause of Death | 1 | 2012 | 3584 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6367 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 1365 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2010 | 1100 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1789 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 6991 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13990 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 2012 | 1624 | 0.010 |
Why?
|
| Age of Onset | 1 | 2006 | 3270 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8628 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2012 | 5316 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 12355 | 0.010 |
Why?
|
| Epilepsy | 1 | 2012 | 3310 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13280 | 0.010 |
Why?
|